Patents by Inventor Matthew J. KADE

Matthew J. KADE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION
    Publication number: 20230405043
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: August 28, 2023
    Publication date: December 21, 2023
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • Proton-binding polymers for oral administration
    Patent number: 11738041
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Grant
    Filed: April 19, 2022
    Date of Patent: August 29, 2023
    Assignee: RENOSIS, INC.
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION
    Publication number: 20220339186
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: April 19, 2022
    Publication date: October 27, 2022
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Jerry M. BUYSSE, Michael J. COPE, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • HCl-binding compositions for and methods of treating acid-base disorders
    Patent number: 11406661
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: August 9, 2022
    Assignee: TRICIDA, INC.
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • Proton-binding polymers for oral administration
    Patent number: 11311571
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: April 26, 2022
    Assignee: TRICIDA, INC.
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION
    Publication number: 20220096534
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: December 9, 2021
    Publication date: March 31, 2022
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Jerry M. BUYSSE, Michael J. COPE, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS
    Publication number: 20220062328
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: September 24, 2021
    Publication date: March 3, 2022
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Jerry M. BUYSSE, Michael J. COPE, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • Proton-binding polymers for oral administration
    Patent number: 11197887
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: December 14, 2021
    Assignee: TRICIDA, INC.
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • CROSSLINKED POLY(ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210347925
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of a target species from the gastrointestinal tract would provide physiological benefits.
    Type: Application
    Filed: January 11, 2021
    Publication date: November 11, 2021
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • COMPOSITIONS FOR TREATING ACID-BASE DISORDERS
    Publication number: 20210205351
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 8, 2021
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Jerry M. BUYSSE, Michael J. COPE, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • CROSSLINKED POLY(ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210079144
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of a target species from the gastrointestinal tract would provide physiological benefits.
    Type: Application
    Filed: September 21, 2018
    Publication date: March 18, 2021
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • Crosslinked poly(allylamine) polymer pharmaceutical compositions
    Patent number: 10934380
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of a target species from the gastrointestinal tract would provide physiological benefits.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: March 2, 2021
    Assignee: TRICIDA, INC.
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION
    Publication number: 20200206260
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: August 16, 2019
    Publication date: July 2, 2020
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Jerry M. BUYSSE, Michael J. COPE, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS
    Publication number: 20200054669
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: May 5, 2017
    Publication date: February 20, 2020
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Jerry M. BUYSSE, Michael J. COPE, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • Proton-binding polymers for oral administration
    Patent number: 10391118
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: August 27, 2019
    Assignee: TRICIDA, INC
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • Proton-binding polymers for oral administration
    Patent number: 10369169
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: August 6, 2019
    Assignee: TRICIDA, INC.
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION
    Publication number: 20190231812
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: April 4, 2019
    Publication date: August 1, 2019
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Jerry M. BUYSSE, Michael J. COPE, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • Proton-binding polymers for oral administration
    Patent number: 10363268
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: July 30, 2019
    Assignee: TRICIDA, INC.
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • COMPOSITIONS FOR TREATING ACID-BASE DISORDERS
    Publication number: 20190209607
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: May 5, 2017
    Publication date: July 11, 2019
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Jerry M. BUYSSE, Michael J. COPE, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN
  • HCL-BINDING COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS
    Publication number: 20190134076
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: May 5, 2017
    Publication date: May 9, 2019
    Inventors: Gerrit KLAERNER, Eric F. CONNOR, Randi K. GBUR, Matthew J. KADE, Paul H. KIERSTEAD, Jerry M. BUYSSE, Michael J. COPE, Kalpesh N. BIYANI, Son H. NGUYEN, Scott M. TABAKMAN